| Product Code: ETC6854296 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Croatia continued to heavily rely on imports of large molecule drug substance from top exporting countries such as Netherlands, Metropolitan France, Denmark, Belgium, and Sweden. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market in terms of import sources. The impressive compound annual growth rate (CAGR) of 39.62% from 2020 to 2024, coupled with a significant growth rate of 54.84% in 2023-24, underscores the robust expansion of Croatia large molecule drug substance CDMO import market, presenting opportunities and challenges for stakeholders in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Croatia Large Molecule Drug Substance CDMO Market Overview |
3.1 Croatia Country Macro Economic Indicators |
3.2 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Croatia Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Croatia Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Croatia Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drug development services globally |
4.2.2 Growing trend towards outsourcing manufacturing activities to specialized contract development and manufacturing organizations (CDMOs) |
4.2.3 Favorable regulatory environment supporting the development of biologics and large molecule drugs |
4.3 Market Restraints |
4.3.1 High initial investment required for establishing large molecule drug substance manufacturing facilities |
4.3.2 Technological complexities involved in large molecule drug manufacturing processes |
4.3.3 Stringent regulatory requirements and quality standards in the pharmaceutical industry |
5 Croatia Large Molecule Drug Substance CDMO Market Trends |
6 Croatia Large Molecule Drug Substance CDMO Market, By Types |
6.1 Croatia Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Croatia Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Croatia Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Croatia Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Croatia Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Croatia Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Croatia Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Croatia Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Number of new partnerships or collaborations with pharmaceutical companies |
8.2 Percentage of revenue from large molecule drug substance manufacturing services |
8.3 Rate of adoption of advanced technologies in large molecule drug manufacturing operations |
9 Croatia Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Croatia Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Croatia Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Croatia Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Croatia Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Croatia Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Croatia Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |